These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2863295)
21. Cardiovascular and renal hemodynamic effects of intravenous infusions of the selective DA1 agonist, fenoldopam, used alone or in combination with dopamine and dobutamine. Lass NA; Glock D; Goldberg LI Circulation; 1988 Nov; 78(5 Pt 1):1310-5. PubMed ID: 2902941 [TBL] [Abstract][Full Text] [Related]
22. Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure. Packer M; Medina N; Yushak M Am J Cardiol; 1984 Nov; 54(8):1025-9. PubMed ID: 6496324 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study. Anderson JL; Baim DS; Fein SA; Goldstein RA; LeJemtel TH; Likoff MJ J Am Coll Cardiol; 1987 Apr; 9(4):711-22. PubMed ID: 3549837 [TBL] [Abstract][Full Text] [Related]
25. Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy. Miller AB; Conetta DA; Bass TA Am J Cardiol; 1985 May; 55(11):1359-62. PubMed ID: 3993570 [TBL] [Abstract][Full Text] [Related]
26. Effects of dopamine D1 and dopamine D2 receptor agonists on coronary and peripheral hemodynamics. Zhao RR; Fennell WH; Abel FL Eur J Pharmacol; 1990 Nov; 190(1-2):193-202. PubMed ID: 1981750 [TBL] [Abstract][Full Text] [Related]
27. MDL 17,043: short- and long-term cardiopulmonary and clinical effects in patients with heart failure. Rubin SA; Tabak L J Am Coll Cardiol; 1985 Jun; 5(6):1422-7. PubMed ID: 3158690 [TBL] [Abstract][Full Text] [Related]
28. Systemic and pulmonary vascular effects of selective dopamine receptor blockade and stimulation in lambs. Polak MJ; Drummond WH Pediatr Res; 1993 Feb; 33(2):181-4. PubMed ID: 8094550 [TBL] [Abstract][Full Text] [Related]
29. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure. Jamison M; Widerhorn J; Weber L; Campese V; Vasquez J; Hovanessian L; Rahimtoola SH; Elkayam U Am Heart J; 1989 Mar; 117(3):607-14. PubMed ID: 2537556 [TBL] [Abstract][Full Text] [Related]
30. Intravenous fenoldopam infusion in severe heart failure. Patel JJ; Mitha AS; Sareli P; de Vaal JB Cardiovasc Drugs Ther; 1993 Feb; 7(1):97-101. PubMed ID: 8097927 [TBL] [Abstract][Full Text] [Related]
31. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure. Lapp H; Mitrovic V; Franz N; Heuer H; Buerke M; Wolfertz J; Mueck W; Unger S; Wensing G; Frey R Circulation; 2009 Jun; 119(21):2781-8. PubMed ID: 19451356 [TBL] [Abstract][Full Text] [Related]
32. Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure. Awan NA; Evenson MK; Needham KE; Evans TO; Hermanovich J; Taylor CR; Amsterdam E; Mason DT Circulation; 1981 Jan; 63(1):96-101. PubMed ID: 7438412 [TBL] [Abstract][Full Text] [Related]
33. Hemodynamic and myocardial performance characteristics after verapamil use in congestive heart failure. Ferlinz J; Citron PD Am J Cardiol; 1983 May; 51(8):1339-45. PubMed ID: 6846161 [TBL] [Abstract][Full Text] [Related]